• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

fogon's Profile

Avatar:

Membership:

Premium

Person Marks:

4

Total Posts:

154

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

04/03/2014 4:45:03 PM

Personal info

Recent Articles

• Unlocking Foralumab's Promise in Neurological Therapies
• BioStem Technologies Unveils Trial for Diabetic Foot Ulcer Care
• Celebrating Innovation in Self-Service Kiosks for 2024
• United Natural Foods Realigns to Enhance Wholesale Operations
• Innovations in Cell and Gene Therapy at Upcoming Conference
• CURRENC Introduces Innovative AI Solutions for Financial Services
• CIChecked™ Appoints Tyrah Lawson to Enhance Operations Strategy
• Viridian Therapeutics Unveils Ambitious 2025 Plans Amid Success
• Howard Hughes Communities Shine in 2024 Best-Selling Rankings
• Miami Beach Partners with Blue Zones for Health Initiative
• MOMA Therapeutics Breakthrough in Precision Medicine and Licensing
• enBio Corp's New Division Revolutionizes Biomedical Staffing
• uniQure Unveils New Public Offering to Fund Gene Therapy Advancements
• Bigleaf Networks Introduces Bigleaf Cloud Connect for Businesses
• Oritek and Ceva Collaborate on Advanced EV Chipsets for Safety
• Centessa Pharmaceuticals Welcomes Stephen Kanes as CMO
• Butterfly Network Anticipates Strong Revenue Surge in Q4 2024
• Marengo Therapeutics Advances Treatment for Colorectal Cancer
• InMode Prepares for Q4 2024 Financial Results Conference Call
• MDaudit's Strategic Partnership Fuels Future Growth Potential
• Celebrating Leadership: Health Enterprise Partners' New Award
• BlackSky Technology Inc. Announces Upcoming Conference Engagement
• Innovative Partnership Between Univar Solutions and dsm-firmenich
• CDB Aviation's 2024 Achievements Set Stage for Future Success
• Alesta Therapeutics Secures €65M to Develop Novel Rare Disease Treatments
• Exploring Jamie Dimon's Bitcoin Skepticism and Investment Returns
• ScaleReady Celebrates Seattle Children's Win with G-Rex Grant
• Middle-Market CEOs Address Tariff Challenges and Tax Uncertainty
• Garmin Unveils New Montana GPS Series with Enhanced Features
• Viking Therapeutics Launches Phase 2 Trial for VK2735 in Obesity
• Synopsys Celebrates CMA Acceptance of Ansys Acquisition Deal
• BizClik Media Unveils January Issues of FinTech & InsurTech
• Hedia and Glooko Collaborate for Enhanced Diabetes Management
• Merck's Gardasil: A New Era in Male HPV Prevention
• Innovative SiriusXM Features Set to Enhance Mitsubishi Vehicles
• AMD Forms Strategic Alliance with Absci for Healthcare AI Growth
• Micron Technology Plans Major Investment for Singapore Facility
• Scout Motors Reports Increased Demand for Hybrid SUVs
• Adobe Faces Downgrade Amid Concerns Over AI Profitability
• Recent Surge in Moderna Shares Amid Health Concerns
• Exploring the Future of Magnesium Carbonate Market Growth
• UPS Stock Gains Momentum Amid Positive Analyst Predictions
• The Future of Progressive Web Apps: A Lucrative Growth Journey
• Brainlab AG Eyes IPO in Frankfurt, Targeting €2 Billion Valuation
• Soaring Growth of the E-Bike Motor Market Towards 2034
• Hang Seng Index Faces Medium-Term Bearish Outlook Amid Risks
• Carbide Tools Market Set to Surpass $17 Billion by 2032
• Alpha Liquid Terminal Launches Innovative Web3 Node on ChromeOS
• SoSoValue Secures $15 Million to Enhance Crypto Investment Tools
• EyePoint Pharmaceuticals Welcomes Reginald J. Sanders to Board